Clinical Trials Logo

Morphine Dependence clinical trials

View clinical trials related to Morphine Dependence.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04495673 Completed - Clinical trials for Opioid-Related Disorders

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder

Start date: January 11, 2021
Phase: N/A
Study type: Interventional

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcrancial direct current stimulation (tDCS) for new addiction treatments that support long-term abstinence. This study will investigate whether the pairing of dorsolateral prefrontal cortex (DLPFC) stimulation and cognitive training can enhance functional connectivity between DLPFC and nucleus accumbens (NAcc). We have identified higher functional connectivity between DLPFC and NAcc in alcoholics that have successfully maintained abstinence for extended periods of time (7 years). This paired-neuromodulation approach can potentially be used as a therapeutic intervention to decrease substance use probability in addiction (e.g. opioid use disorder). The long term goal is to develop new addiction treatments that support long-term abstinence in opioid use disorder. The overall objective of this proposal is to enhance functional connectivity between DLPFC and NAcc as a therapeutic intervention to enhance cognition and reduce substance use rates in opioid use disorder.

NCT ID: NCT00032968 Completed - Heroin Dependence Clinical Trials

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Start date: January 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess buprenorphine/naloxone versus clonidine for outpatient opiate detoxification.

NCT ID: NCT00032955 Completed - Heroin Dependence Clinical Trials

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

Start date: February 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess buprenorphine/naloxone versus clonidine for inpatient opiate detoxification.